+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Superdisintegrants Market - Growth, Trends, and Forecast (2020 - 2025)

  • ID: 4987054
  • Report
  • February 2020
  • Region: Global
  • 120 pages
  • Mordor Intelligence
1 of 4

FEATURED COMPANIES

  • Asahi Kasei Corporation
  • BASF SE
  • Corel Pharma Chem
  • DFE Pharma
  • DuPont
  • JRS Pharma
  • MORE
The superdisintegrants market studied was expected to grow with a CAGR of approximately 8.1% over the forecast period. The major factors accrediting to the growth of the market are increasing adoption of orally disintegrating tablets, and increasing healthcare expenditure and awareness. Furthermore, the increasing number of pediatric patients and the geriatric population cannot swallow solid forms of medication. These agents are used as a viscosity-improving agent in drug-loaded films, having improved performance, and maintains high drug content uniformity. Superdisintegrants are added to solid dosage forms such as capsules or tablets that aids them to disintegrate when submerged in liquid. Due to this benefit, these are significantly used in the manufacturing of disintegrating oral formulations, which further increases the demand for superdisintegrants in the market. However, the concerns related to safety and quality are the major drawback of market growth.

Key Market Trends

Natural Superdisintegrants segment to register significant growth
  • Natural superdisintegrants such as ispaghulla, gellan gum, fenugreek seed mucilage, and gum karaya, among others have many advantages over synthetic superdisintegrants, such as biodegradability, chemical inertness, and non-toxicity. Moreover, it can be modified in several ways in order to obtain tailor-made materials for drug delivery systems that aim to enhance safety by the formulation of an accessible dosage.
  • The major factors propelling the segment growth are the increasing number of pediatric patients and the geriatric population, expansion of generic drugs market, increase of new superdisintegrants.
North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall superdisintegrants market, throughout the forecast period. The market growth is due to factors such as the presence of key players, established healthcare infrastructure, and availability of funding for research and development for advanced drug delivery methods. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase market growth. In this region, the United States has the maximum share due to supportive healthcare policies, the high number of patients, and a developed healthcare market.

Competitive Landscape

The Superdisintegrants market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market BASF SE, Ashland Global Holdings Inc., DuPont., Roquette Freres, DFE Pharma, JRS Pharma, Asahi Kasei Corporation, Merck KGaA, and Corel Pharma Chem.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format.
  • Report customization as per the client's requirements.
  • 3 months of analyst support.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Asahi Kasei Corporation
  • BASF SE
  • Corel Pharma Chem
  • DFE Pharma
  • DuPont
  • JRS Pharma
  • MORE
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Adoption of Orally Disintegrating Tablets
4.2.2 Increase Healthcare Expenditure and Awareness
4.2.3 Increasing Number of Pediatric Patients and Geriatric Population
4.3 Market Restraints
4.3.1 Concerns About the Safety and Quality of Product
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Product Type
5.1.1 Natural Superdisintegrants
5.1.2 Synthetic Superdisintegrants
5.1.2.1 Modified Starch
5.1.2.2 Modified Cellulose
5.1.2.3 Crospovidone
5.1.2.4 Calcium Silicates
5.1.2.5 Ion Exchange Resins
5.1.3 Others
5.2 By Formulation
5.2.1 Tablets
5.2.2 Capsules
5.3 By Therapeutic Area
5.3.1 Neurological Diseases
5.3.2 Gastrointestinal Diseases
5.3.3 Oncology
5.3.4 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles
6.1.1 BASF SE
6.1.2 Ashland Global Holdings Inc.
6.1.3 DuPont
6.1.4 Roquette Freres
6.1.5 DFE Pharma
6.1.6 JRS Pharma
6.1.7 Asahi Kasei Corporation
6.1.8 Merck KGaA
6.1.9 Corel Pharma Chem

7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • BASF SE
  • Ashland Global Holdings Inc.
  • DuPont
  • Roquette Freres
  • DFE Pharma
  • JRS Pharma
  • Asahi Kasei Corporation
  • Merck KGaA
  • Corel Pharma Chem
Note: Product cover images may vary from those shown
Adroll
adroll